Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
- PMID: 32503857
- PMCID: PMC7307213
- DOI: 10.1136/annrheumdis-2020-217948
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
Keywords: arthritis, rheumatoid; autoimmune diseases; autoimmunity; lupus erythematosus, systemic; spondylitis, ankylosing.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871. Epub 2020 May 29. Ann Rheum Dis. 2020. PMID: 32471903 Free PMC article.
-
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.Ann Rheum Dis. 2020 Dec;79(12):1659-1661. doi: 10.1136/annrheumdis-2020-218054. Epub 2020 Jun 30. Ann Rheum Dis. 2020. PMID: 32606046 Free PMC article. No abstract available.
-
Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.Rheumatol Int. 2020 Oct;40(10):1593-1598. doi: 10.1007/s00296-020-04676-4. Epub 2020 Aug 13. Rheumatol Int. 2020. PMID: 32794113 Free PMC article.
-
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.Rheumatol Int. 2020 Oct;40(10):1707-1716. doi: 10.1007/s00296-020-04635-z. Epub 2020 Jun 26. Rheumatol Int. 2020. PMID: 32591970 Free PMC article. Review.
-
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.Arthritis Rheumatol. 2020 Aug;72(8):1241-1251. doi: 10.1002/art.41301. Epub 2020 Jun 5. Arthritis Rheumatol. 2020. PMID: 32349183
Cited by
-
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.Eur J Intern Med. 2021 Apr;86:34-40. doi: 10.1016/j.ejim.2021.01.016. Epub 2021 Feb 5. Eur J Intern Med. 2021. PMID: 33581979 Free PMC article.
-
Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic.Front Med (Lausanne). 2020 Oct 9;7:562142. doi: 10.3389/fmed.2020.562142. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33154972 Free PMC article. Review.
-
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.J Clin Immunol. 2021 Oct;41(7):1425-1442. doi: 10.1007/s10875-021-01068-6. Epub 2021 Jun 8. J Clin Immunol. 2021. PMID: 34101091 Free PMC article. No abstract available.
-
Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis.Rheumatol Int. 2021 May;41(5):851-861. doi: 10.1007/s00296-021-04803-9. Epub 2021 Mar 9. Rheumatol Int. 2021. PMID: 33687528 Free PMC article.
-
COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review.Rheumatol Int. 2021 Aug;41(8):1509-1514. doi: 10.1007/s00296-021-04905-4. Epub 2021 Jun 6. Rheumatol Int. 2021. PMID: 34091704 Free PMC article. Review.
References
-
- (CCAES) CdCdAyES. Enfermedad POR nuevo coronavirus, COVID-19. Situación actual, 2020. Available: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual... [Accessed cited 2020 21/05/2020].
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources